Pharma M&A Outlook Shifts: Big Deals Eyed Amid Mercedes-Benz Valuation Questions

The outlook for significant merger and acquisition activity within the pharmaceutical sector is a key focus for investors and operators. While specific deal catalysts remain fluid, the potential for large-scale consolidation could reshape the healthcare…